# RadioEmbolization for the ADvancement of Y90 Glass Microspheres Registry

> **NCT03516695** · — · TERMINATED · sponsor: **Boston Scientific Corporation** · enrollment: 95 (actual)

## Conditions studied

- Liver Cancer

## Interventions

- **DEVICE:** TheraSphere®

## Key facts

- **NCT ID:** NCT03516695
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-23
- **Primary completion:** 2018-12-12
- **Final completion:** 2018-12-12
- **Target enrollment:** 95 (ACTUAL)
- **Why stopped:** due to Sponsor's ongoing and upcoming projects and overall research priorities
- **Last updated:** 2021-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03516695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03516695, "RadioEmbolization for the ADvancement of Y90 Glass Microspheres Registry". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03516695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*